Back
Seelos Therapeutics Vs. Citius Pharmaceuticals Industry Stock Comparison
Buy
51
SEEL
Seelos Therapeutics
Last Price:
3.95
Seasonality Move:
-7.57%
Sell
13
CTXR
Citius Pharmaceuticals
Last Price:
0.52
Seasonality Move:
-8.52%
Buy
51
Seelos Therapeutics (SEEL)
is a Buy
Is Seelos Therapeutics a Buy, Sell or Hold?
- The current Seelos Therapeutics [SEEL] share price is $5.00. The Score for SEEL is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- SEEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy, Sell or Hold?
- The current Citius Pharmaceuticals [CTXR] share price is $0.52. The Score for CTXR is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- CTXR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SEEL Stock Price Chart
What is Seelos Therapeutics's stock price today?
-
The Seelos Therapeutics share price today is $5.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SEEL is experiencing slight buying pressure.
CTXR Stock Price Chart
What is Citius Pharmaceuticals's stock price today?
-
The Citius Pharmaceuticals share price today is $0.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SEEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 56.29 | Buy |
| Chaikin Money Flow: | 119970 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (-0.49 - 1.37) | Buy |
| Bollinger Bands (100): | (0.04 - 1.54) | Buy |
CTXR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 39.64 | Sell |
| Chaikin Money Flow: | 585049 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.51 - 0.59) | Sell |
| Bollinger Bands (100): | (0.54 - 0.8) | Sell |
SEEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.83 | Buy |
| 20-day SMA: | 0.47 | Buy |
| 50-day SMA: | 0.4 | Buy |
| 200-day SMA: | 4.16 | Buy |
| 8-day EMA: | 1.3 | Buy |
| 20-day EMA: | 0.7 | Buy |
| 50-day EMA: | 0.62 | Buy |
| 200-day EMA: | 23.27 | Sell |
CTXR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.53 | Sell |
| 20-day SMA: | 0.53 | Sell |
| 50-day SMA: | 0.68 | Sell |
| 200-day SMA: | 0.71 | Sell |
| 8-day EMA: | 0.53 | Sell |
| 20-day EMA: | 0.55 | Sell |
| 50-day EMA: | 0.62 | Sell |
| 200-day EMA: | 0.72 | Sell |
Seelos Therapeutics Earnings Growth & SEEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $16.80 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.10 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Seelos Therapeutics Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Citius Pharmaceuticals Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||